Working… Menu

Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02933788
Recruitment Status : Unknown
Verified October 2016 by Ji Hyun Kim, Kangbuk Samsung Hospital.
Recruitment status was:  Not yet recruiting
First Posted : October 14, 2016
Last Update Posted : October 14, 2016
Asan Medical Center
Information provided by (Responsible Party):
Ji Hyun Kim, Kangbuk Samsung Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2016
Estimated Study Completion Date : December 2018
Global status report on noncommunicable diseases 2010